Best Researcher Award
Mohana Vamsi Nuli – Penn Life Sciences
The researcher profile presented here is intended as an academic recognition article for the Best Researcher Award. The award context emphasizes documented research activity, publication quality, subject relevance, methodological contribution, and scholarly visibility. Bibliographic information and publication examples are presented as evidence for evaluating research suitability rather than as an independent assessment of scientific merit.
Abstract
Mohana Vamsi Nuli’s research profile is centered on pharmaceutical analysis and analytical method development, with published work addressing chromatographic techniques, quality-by-design methodology, and sustainable analytical practices. Available bibliographic records identify contributions to HPLC, UHPLC, and LC-MS/MS applications for pharmaceutical and biological samples. [1] [2] These areas are closely aligned with contemporary pharmaceutical research, where reliable analytical procedures are important for characterization, quantification, validation, and quality assessment.
Keywords
Pharmaceutical Analysis; HPLC; UHPLC; LC-MS/MS; Quality by Design; Analytical Chemistry; Green Analytical Chemistry; Method Validation; Pharmaceutical Quality; Chromatography; Drug Analysis; Best Researcher Award.
Introduction
Pharmaceutical analysis provides analytical foundations for drug development, formulation assessment, quality control, and biological measurement. Research in this field increasingly combines chromatographic optimization with experimental design and sustainability considerations. Nuli’s documented publications reflect this direction through studies involving UHPLC, RP-HPLC, LC-MS/MS, and quality-by-design strategies. [2] [3]
Research Profile
The supplied researcher profile records 30 documents, 227 citations, and an h-index of 7, indicating a measurable publication and citation record. The Scopus author record identifies Mohana Vamsi Nuli under Scopus ID 58194986900. His scholarly work includes analytical method development and validation, with research extending to pharmaceutical dosage forms, biological matrices, impurities, and analytical quality assessment.
Research Contributions
A notable theme is the use of design-based analytical development. His 2024 publication on molnupiravir applied Box-Behnken experimental design to UHPLC method development and impurity quantification. [2] Another study applied analytical quality by design to RP-UPLC determination of nivolumab and relatlimab, demonstrating relevance to modern pharmaceutical quality evaluation. [3]
Publications
The publication record includes recent studies in sustainable analytical chemistry and pharmaceutical analysis. Examples include research on ambrisentan-loaded solid lipid nanoparticles, green RP-HPLC determination of phenolic acids, and sustainable UHPLC analysis of antiviral combinations. [1] [4] [5] These publications illustrate a continuing interest in analytical robustness, optimization, and environmentally conscious methodologies.
Research Impact
Research impact can be considered through publication activity, citation indicators, methodological relevance, and contribution to pharmaceutical analytical practice. The supplied profile reports 227 citations and an h-index of 7, while the Scopus record reports 30 documents. These indicators provide quantitative context, although citation metrics should be interpreted alongside publication quality, research originality, methodological rigor, and field-specific standards.
Award Suitability
The documented profile is relevant to a Best Researcher Award in pharmaceutical analysis because it combines sustained publication activity with research addressing contemporary analytical challenges. The portfolio includes quality-by-design methods, chromatographic analysis, pharmaceutical impurity assessment, and green analytical approaches. [1] [3] Final award decisions should additionally consider the complete submission, verified publication record, originality, peer-reviewed impact, and the applicable evaluation criteria of the International Top Pharmaceutical Awards.
Conclusion
Mohana Vamsi Nuli presents a research profile focused on pharmaceutical analysis and analytical method development. His documented work spans chromatographic technologies, quality-by-design approaches, impurity analysis, and sustainable analytical chemistry. The combination of publication activity and reported citation indicators provides a reasonable academic basis for consideration under a Best Researcher Award framework. [2] [4]
External Links
References
- Singh, M., Tatapudi, H. K., Kanugo, A., Jaini, P. K., & Nuli, M. V. (2026). Application of sustainable QbD based HPLC method for quantification of carboxylic-diphenyl methane drug ambrisentan loaded in solid lipid nanoparticles. Sustainable Chemistry One World, 9, 100158.DOI: https://doi.org/10.1016/j.scowo.2025.100158
- Nuli, M. V., Bhikshapathi, D., Garige, A. K., Chandupatla, V., Sunkara, S. L., & Grover, P. (2024). Ultra-high-performance liquid chromatography method development for the quantification of Molnupiravir and its process-related impurities using Box-Behnken experimental design. Separation Science Plus, 7(4).DOI: https://doi.org/10.1002/sscp.202300213
- Nuli, M. V., Seemaladinne, R., & Tallam, A. K. (2024). Analytical quality by design (AQbD) based optimization of RP-UPLC method for determination of nivolumab and relatlimab in bulk and pharmaceutical dosage forms. Future Journal of Pharmaceutical Sciences, 10.DOI: https://doi.org/10.1186/s43094-024-00659-5
- Nuli, M. V., Jaini, P. K., Jami, D., Tummala, S. R., Chukka, A. K., & Tatapudi, H. K. (2025). Sustainable Quality by Design Approach Based UHPLC Technique for Triple Combination Antiviral Drugs: Appraisal of Green and White Metrics. Separation Science Plus, 8(6).DOI: https://doi.org/10.1002/sscp.70085
- Repudi, L., Nuli, M. V., Jaini, P. K., Seemaladinne, R., Chagarlamudi, K., & Gandla, K. (2026). Green and Robust RP-HPLC for Simultaneous Quantification of Gallic, Ferulic, and Caffeic Acids in Human Plasma via Box-Behnken Design-Based Optimization. Drug Metabolism and Bioanalysis.DOI: https://doi.org/10.2174/0118723128455332260605064308